Cargando…
Introduction of Clusterin Gene into Human Renal Cell Carcinoma Cells Enhances Their Resistance to Cytotoxic Chemotherapy through Inhibition of Apoptosis both in vitro and in vivo
Recent studies have revealed the powerful antiapoptotic activity of clusterin in various malignant tumors; however, the significance of clusterin expression in the acquisition of a resistant phenotype against several kinds of treatment in human renal cell carcinoma (RCC) has not been well characteri...
Autores principales: | Hara, Isao, Miyake, Hideaki, Gleave, Martin E., Kamidono, Sadao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926662/ https://www.ncbi.nlm.nih.gov/pubmed/11714447 http://dx.doi.org/10.1111/j.1349-7006.2001.tb02143.x |
Ejemplares similares
-
Rejection of Mouse Renal Cell Carcinoma Elicited by Local Secretion of Interleukin‐2
por: Hara, Isao, et al.
Publicado: (1996) -
Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model
por: Kususda, Y, et al.
Publicado: (2012) -
Optimal timing and dosage of chemotherapy as a combined treatment with androgen withdrawal in the human prostate LNCaP tumour model
por: Miyake, H, et al.
Publicado: (2001) -
Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis
por: Scaltriti, M, et al.
Publicado: (2004) -
AB170. Molecular biology for genitourinary system diseases and sexual dysfunction clusterin produced by Sertoli cells inhibits heat stress-induced apoptosis in the rat testis
por: Matsushita, Kei, et al.
Publicado: (2015)